Panel recommends AutoPap as a primary screening tool for cervical cancer
This article was originally published in Clinica
Executive Summary
An FDA panel has said that an automated method for analysing cervical smears can be used as a front-line test to rule out cervical cancer in patients who are screened for the disease.